Showing results (31-40 of 51) with videos related to
Sort By:
Pageof 6
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|May 29, 2012
Comparison of serum and bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis in solid-organ transplant recipientsPayam Tabarsi, Abdolreza Soraghi, Majid Marjani, et al.Scandinavian Journal of Infectious Diseases|November 28, 2008
Is standardized treatment appropriate for non-XDR multiple drug resistant tuberculosis cases? A clinical descriptive studyPayam Tabarsi, Parvaneh Baghaei, Sara Jalali, et al.Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|January 13, 2015
Mycobacterial infection and the impact of rifabutin treatment in organ transplant recipients: a single-center studyPayam Tabarsi, Maham Farshidpour, Majid Marjani, et al.Annals of Thoracic Medicine|May 17, 2011
Factors associated with death or intensive care unit admission due to pandemic 2009 influenza A (H1N1) infectionPayam Tabarsi, Ahmadreza Moradi, Majid Marjani, et al.Respirology (Carlton, Vic.)|January 17, 2008
Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in IranPayam Tabarsi, Azar Nooraki, Mehdi Mirsaeidi, et al.American Journal of Therapeutics|June 11, 2010
Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment casesPayam Tabarsi, Ehsan Chitsaz, Vahid Tabatabaei, et al.Tanaffos|October 19, 2022
Evaluations of Factors Affecting of Short-and Long-Time of Occurrence of Disease Relapse in Patients with Tuberculosis Using Parametric Mixture Cure Model: A Cohort StudyMehdi Kazempour-Dizaji, Mohammad Varahram, Payam Tabarsi, et al.American Journal of Therapeutics|June 19, 2009
Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis casesParvaneh Baghaei, Payam Tabarsi, Ehsan Chitsaz, et al.Journal of Infection in Developing Countries|January 14, 2012
Pulmonary disease caused by Mycobacterium simiae in Iran's national referral center for tuberculosisParvaneh Baghaei, Payam Tabarsi, Parissa Farnia, et al.International Immunopharmacology|June 17, 2020
Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trialFarzaneh Dastan, Seyed Alireza Nadji, Ali Saffaei, et al.Pageof 6